Fresenius Kabi received regulatory approvals from the EMA and FDA for a vedolizumab biosimilar, while excluding commercialization in the Middle East and North Africa.
1 report, 1 independent
Updated Jul 31
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Fresenius Kabi received regulatory approvals from the EMA and FDA for a vedolizumab biosimilar, while excluding commercialization in the Middle East and North Africa.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Fresenius Kabi
company based in Bad Homborg, Germany; offers health products for the critically and chronically ill.
Nothing else this week.
-
European Medicines Agency
highest regulatory authority on medicines in the European Union
- FDA